sycrest
n.v. organon - asenapine (as maleate) - disturb bipolari - psikolettiċi - sycrest huwa indikat għall-kura ta 'episodji manijaċi moderati sa severi assoċjati ma' disturb bipolari i fl-adulti.
evarrest
omrix biopharmaceuticals n. v. - fibrinoġen uman, trombina umana - hemostasi - lokali hemostatics - trattament ta 'sostenn f'operazjoni adulta fejn it-tekniki kirurġiċi standard mhumiex biżżejjed (ara sezzjoni 5. 1):- għat-titjib ta'l-emostażi.
velphoro
vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - - mediċini għal-kura tal-iperkalimja u ' l-iperphosphatemija - velphoro huwa indikat għall-kontroll ta 'livelli ta' fosfru fis-serum f'pazjenti b'mard tal-kliewi kroniku adulti (ckd) fuq emodijaliżi (hd) jew dijalisi peritoneali (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.
actraphane
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
actrapid
novo nordisk a/s - insulina umana - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
levemir
novo nordisk a/s - insulin detemir - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal ta 'sena u aktar.
mixtard
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
novomix
novo nordisk a/s - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
ryzodeg
novo nordisk a/s - insulina aspart, l-insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus f'adulti, adolexxenti u tfal mill-età ta 'sentejn.
tresiba
novo nordisk a/s - insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus fl-adulti.